대사체학 : 기술과 세계 시장

The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.

The global market for separation techniques for metabolomics technologies is expected to grow from $8.3 billion in 2024 and is projected to reach $15.4 billion by the end of 2029, at a CAGR of 13.1% during the forecast period of 2024 to 2029.

The global market for detection techniques for metabolomics technologies is expected to grow from $8.0 billion in 2024 and is projected to reach $14.8 billion by the end of 2029, at a CAGR of 13.0% during the forecast period of 2024 to 2029.

Report Scope

This report is a comprehensive study of the global metabolomics technologies market. Current and historical market revenues are estimated based on product, indication, application and region.

Report Includes

• 32 data tables and 39 additional tables
• An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms
• Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
• Evaluation of the current market's size and revenue growth prospects, along with a market share analysis by product, indication, application, and region
• Analysis of the market drivers, restraints and opportunities, and identification of the companies best positioned to meet the demand for metabolics
• A look at ESG trends
• Information on developments in R&D, clinical trials, emerging technologies, and economic trends
• Analysis of key companies' market shares, proprietary technologies, patents, and alliances
• Profiles of the leading companies, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker, Danaher Corp., and Merck KGaA

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Overview of Metabolomics
• Separation Techniques
• Detection Techniques
• Metabolites and Their Applications
• R&D and Regulatory Approval
• Supply Chain Analysis

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Technological Advancements
• Increasing Healthcare Expenditure
• Expanding Applications Across Industries
• Market Restraints
• High Cost of Instruments and Services
• Complexity of Data Analysis
• Standardization and Quality Control Challenges
• Limited Biomarker Validation and Clinical Utility
• Market Opportunities
• Precision Medicine and Personalized Healthcare
• Drug Discovery and Development
• Biomarker Discovery and Validation
• Nutritional Profiling and Functional Foods
• Environmental Monitoring and Toxicology
• Market Challenges
• Data Complexity and Interpretation
• Standardization and Quality Assurance
• Biomarker Validation and Clinical Translation
• Technological Limitations and Costs
• Regulatory and Ethical Considerations

Chapter 4 Emerging Technologies and Developments

• Introduction
• Clinical Trial Analysis
• By Study Type
• By Status
• By Gender
• By Interventions
• Granted Patents
• Introduction
• Patent Analysis

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Metabolomics Market, by Product
• Global Market Analysis and Forecast
• Separation Techniques
• Detection Techniques
• Metabolomics Market, by Indication
• Global Market Analysis and Forecast
• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Inborn Errors of Metabolism
• Other Diseases Indication
• Metabolomics Market, by Application
• Global Market Analysis and Forecast
• Biomarker Discovery
• Drug Discovery
• Toxicology Testing
• Nutrigenomics
• Functional Genomics
• Others
• Geographic Breakdown
• Metabolomics Market, by Region
• Global
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Company Share Analysis
• Strategic Analysis
• Mergers and Acquisitions
• Venture Capital Funding

Chapter 7 Appendix

• Methodology
• Sources
• Acronyms
• Definitions/Taxonomy
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• BIO-RAD LABORATORIES INC.
• BRUKER
• DANAHER CORP.
• MERCK KGAA
• SHIMADZU CORP.
• THERMO FISHER SCIENTIFIC INC.
• WATERS CORP.